These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23462143)

  • 1. Treatment with 5-azacytidin upregulates the expression of CD20 in CD20-negative B cell acute lymphoblastic leukemia: a case report.
    Rahmé R; Benayoun E; Pautas C; Cordonnier C; Wagner-Ballon O; Maury S
    Exp Hematol; 2013 Jun; 41(6):505-7. PubMed ID: 23462143
    [No Abstract]   [Full Text] [Related]  

  • 2. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
    Claviez A; Eckert C; Seeger K; Schrauder A; Schrappe M; Henze G; von Stackelberg A
    Haematologica; 2006 Feb; 91(2):272-3. PubMed ID: 16461321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
    Dworzak MN; Schumich A; Printz D; Pötschger U; Husak Z; Attarbaschi A; Basso G; Gaipa G; Ratei R; Mann G; Gadner H
    Blood; 2008 Nov; 112(10):3982-8. PubMed ID: 18780832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
    Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F
    Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early relapse after rituximab chemoimmunotherapy.
    Kiss F; Buslig J; Szegedi I; Scholtz B; Kappelmayer J; Kiss C
    Pediatr Blood Cancer; 2008 Feb; 50(2):372-5. PubMed ID: 17973316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells.
    Shimizu R; Kikuchi J; Wada T; Ozawa K; Kano Y; Furukawa Y
    Leukemia; 2010 Oct; 24(10):1760-8. PubMed ID: 20686505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.
    Alencar C; Abramowtiz M; Parekh S; Braunshweig I; Jacobson M; Silverman L; Verma A
    Am J Hematol; 2009 Oct; 84(10):688-9. PubMed ID: 19722261
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report.
    Tsutsumi Y; Ohigashi H; Ito S; Shiratori S; Teshima T
    J Med Case Rep; 2016 Feb; 10():27. PubMed ID: 26838941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
    Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
    Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia.
    Mattison RJ; Larson RA
    Curr Opin Oncol; 2009 Nov; 21(6):601-8. PubMed ID: 19713843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.
    Stryckmans P; De Witte T; Marie JP; Fillet G; Peetermans M; Bury J; Muus P; Andrien JM; Hayat M; Jaksic B
    Leukemia; 1992; 6 Suppl 2():199-203. PubMed ID: 1578934
    [No Abstract]   [Full Text] [Related]  

  • 16. Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.
    Sugimoto T; Tomita A; Hiraga J; Shimada K; Kiyoi H; Kinoshita T; Naoe T
    Biochem Biophys Res Commun; 2009 Dec; 390(1):48-53. PubMed ID: 19769942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of acute lymphoblastic leukemia in adults.
    Hoelzer D
    Leukemia; 1992; 6 Suppl 2():132-5. PubMed ID: 1578915
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent aleukemic leukemia cutis in a patient with pre-B-cell acute lymphoblastic leukemia.
    Ansell LH; Mehta J; Cotliar J
    J Clin Oncol; 2013 Jul; 31(20):e353-5. PubMed ID: 23733764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
    Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
    [No Abstract]   [Full Text] [Related]  

  • 20. Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
    Szatrowski TP; Dodge RK; Reynolds C; Westbrook CA; Frankel SR; Sklar J; Stewart CC; Hurd DD; Kolitz JE; Velez-Garcia E; Stone RM; Bloomfield CD; Schiffer CA; Larson RA
    Cancer; 2003 Mar; 97(6):1471-80. PubMed ID: 12627512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.